Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014, 158(2):181-188 | DOI: 10.5507/bp.2014.016
Xanthomas: Clinical and pathophysiological relations
- 4 th Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague and General Faculty Hospital in Prague, Czech Republic
Background: Xanthomas are well circumscribed lesions in the connective tissue of the skin, tendons or fasciae that predominantly consist of foam cells; these specific cells are formed from macrophages as a result of an excessive uptake of low density lipoprotein (LDL) particles and their oxidative modification.
Results: Until recently, xanthelasma was considered to be only a cosmetic lesion; however, according to the results of recent prospective studies it is connected with an increased cardiovascular risk and reduced average lifespan. Pathogenetic mechanisms involved in the development of xanthomas resemble early stages of atherogenesis. In clinical practice, xanthomas can signalise various congenital or acquired dyslipidemias. The most prevalent form of xanthomas is xanthelasma palpebrarum. Tendinous and tuberous xanthomas are typical for autosomal dominant hypercholesterolemia, as well as for some rare conditions, such as cerebrotendinous xanthomatosis and familial β-sitosterolemia. In patients with familial hypercholesterolemia, the presence of tendinous xanthomas has been shown to be associated with a two to four times higher risk for cardiovascular disease. Eruptive xanthomas are skin manifestations of a severe hypertriglyceridemia and implicate an elevated risk for acute pancreatitis or type 2 diabetes mellitus. Xanthoma striatum palmare is pathognomic for primary dysbetalipoproteinemia, whereas diffuse plane xanthomas are frequently associated with paraproteinemia and lymphoproliferative disorders.
Conclusion: Thorough familiarity with the clinical presentation of xanthomas helps in the diagnosis and follow-up of different forms of dyslipidemia. Moreover, xanthelasma palpebrarum, the most prevalent form of xanthomas, is connected with increased risk of atherothrombotic disease independently of conventional cardiovascular risk factors. To fully understand the pathogenesis, further experimental and clinical research is required.
Keywords: xanthoma, dyslipidemia, oxidatively modified low density lipoproteins, foam cells, inflammation, cardiovascular risk
Received: November 13, 2013; Accepted: March 28, 2014; Prepublished online: April 29, 2014; Published: June 23, 2014 Show citation
References
- Koumar V, Abbas AK, Fausto N, Aster JC, editors. Robbins and Cotran Pathologic Basis of Disease. 8th ed. Philadelphia: Saunders Elsevier; 2010.
- Török L. Dermatological manifestations in internal diseases (in Czech). Heidelberg - Leipzig - Praha: J.A. Barth Verlag a ČLS J. E. Purkyně; 1998.
- Renner R, Teuwen I, Harth W, Treudler R, Simon JC. Eruptive xanthomas with hypertriglyceridemia. Hautarzt 2008;59(12):995-9.
Go to original source...
Go to PubMed...
- Durrington P, Sniderman A, editors. Hyperlipidaemia. Oxford: Health Press; 2000.
- Alam M, Garzon MC, Salen G, Starc TJ. Tuberous xanthomas in sitosterolemia. Pediatr Dermatol 2000;17(6):447-9.
Go to original source...
Go to PubMed...
- Kalidas K, Behrouz R. Inherited metabolic disorders and cerebral infarction. Expert Rev Neurother 2008;8(11):1731-41.
Go to original source...
Go to PubMed...
- Thompson GR, editor. A Handbook of Hyperlipidemia. London: Current Science; 1990.
- Miller YI, Tsimikas S. Lipoprotein oxidation and modification. High-density lipoprotein metabolism. In: Ballantyne CM, editor. Clinical Lipidology. A Companion to Braunwald´s Heart Disease. Philadelphia: Saunders Elsevier; 2009, p. 93-110.
Go to original source...
- Xu S, Ogura S, Chen J, Little PJ, Mos J, Liu P. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci 2013;70(16):2859-72.
Go to original source...
Go to PubMed...
- Brewer HB. High-density lipoprotein metabolism. In: Ballantyne CM, editor. Clinical Lipidology. A Companion to Braunwald´s Heart Disease. Philadelphia: Saunders Elsevier; 2009, p. 45-55.
Go to original source...
- Toth PP. High-density lipoprotein. In: MH Davidson, PP Toth, KC Maki (eds.) Therapeutic Lipidology. Totowa, NJ, Humana Press 2007, 159-99.
Go to original source...
- Lim HY, Thiam CH, Yeo KP, Bisoendial R, Hii CS, McGrath KC, Tan KW, Heather A, Alexander JS, Angeli V. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell Metab 2013;17(6):671-84.
Go to original source...
Go to PubMed...
- Martel C, Li W, Fulp B, Platt AM, Gautier EL, Westerterp M, Bittman R, Tall AR, Chen SH, Thomas MJ, Kreisel D, Swartz MA, Sorci-Thomas MG, Randolph GJ. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest 2013;123(4):1571-9.
Go to original source...
Go to PubMed...
- Tsouli SG, Kiortsis DN, Argyropoulou MI, Mikhailidis DP, Elisaf MS Pathogenesis, detection and treatment of Achilles tendon xanthomas. Eur J Clin Invest 2005;35(4):236-44.
Go to original source...
Go to PubMed...
- Civeira F, Castillo S, Alonso R, Meriño-Ibarra E, Cenarro A, Artied M, Martín-Fuentes P, Ros E, Pocoví M, Mata P, Spanish Familial Hypercholesterolemia Group. Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation. Arterioscler Thromb Vasc Biol 2005;25(9):1960-5.
Go to original source...
Go to PubMed...
- Matsuura F, Hirano K, Koseki M, Ohama T, Matsuyama A, Tsujii K, Komuro R, Nishida M, Sakai N, Hiraoka H, Nakamura T, Yamashita S. Familial massive tendon xanthomatosis with decreased high-density lipoprotein-mediated cholesterol efflux. Metabolism 2005;54(8):1095‑101.
Go to original source...
Go to PubMed...
- Hirata Y, Okawa K, Ikeda M, Seike M, Matsumoto M, Kodama H. Low density lipoprotein oxidized in xanthoma tissue induces the formation and infiltration of foam cells. J Dermatol Sci 2002;30(3):248-55.
Go to original source...
Go to PubMed...
- Wen Y, Leake DS. Low density lipoprotein undergoes oxidation within lysosomes in cells. Circ Res 2007;100(9):1337-43.
Go to original source...
Go to PubMed...
- Namazi MR, Sharifian M. The potential anti-xanthoma and anti-atherosclerotic effects of proton pump inhibitors. J Clin Pharm Ther 2008;33(6):579-80.
Go to original source...
Go to PubMed...
- Artieda M, Cenarro A, Junquera C, Lasierra P, Martínez-Lorenzo MJ, Pocoví M, Civeira F. Tendon xanthomas in familial hypercholesterolemia are associated with differential inflammatory response of macrophages to oxidized LDL. FEBS Lett 2005;579(20):4503-12.
Go to original source...
Go to PubMed...
- Jeziorska M, Hassan A, Mackness MI, Woolley DE, Tullo AB, Lucas GS, Durrington PN. Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis. J Clin Pathol 2003;56(1):64-8.
Go to original source...
Go to PubMed...
- Szalat R, Arnulf B, Karlin L, Rybojad M, Asli B, Malphettes M, Galicier L, Vignon-Pennamen MD, Harel S, Cordoliani F, Fuzibet JG, Oksenhendler E, Clauvel JP, Brouet JC, Fermand JP. Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy. Blood 2011;118(14):3777-84.
Go to original source...
Go to PubMed...
- ©tork J. Cutaneous conditions in disorders of metabolism and nutrition (in Czech). In: ©tork J, Arenberger P, Pizinger K, Semrádová V, Vosmík F, editors. Dermatovenerologie. Praha: Galén - Karolinum; 2008, p. 259-274.
- Singh RK, Simalti AK. Tuberous xanthoma. Indian Pediatr 2009;46(8):727.
Go to PubMed...
- Clayton PT. Disorders of bile acid synthesis. J Inherit Metab Dis 2011;34(3):593-604.
Go to original source...
Go to PubMed...
- Spanou Z, Borradori L. Diffuse plane xanthomas, a cutaneous marker for monoclonal gammopathies and lymphoproliferative diseases. Eur J Haematol 2010;86(1):91.
Go to original source...
Go to PubMed...
- Nagarajan DV, Boreham PA, Parfitt VJ. Palmar striated xanthomas. Postgrad Med J 2003;79(938):690.
Go to original source...
- ®ák A, Zeman M. Secondary dyslipoproteinemias (in Czech). In: Svačina ©, editor. Disorders of metabolism and nutrition. Praha: Galén; 2010, p. 271-288.
- Kim J, Kim YJ, Lim H, Lee SI. Bilateral circular xanthelasma palpebrarum. Arch Plast Surg 2012;39(4):435-7.
Go to original source...
Go to PubMed...
- Bergman R. Xanthelasma palpebrarum and risk of atherosclerosis. Int J Dermatol 1998;37(5):343-5.
Go to original source...
Go to PubMed...
- Christoffersen M, Frikke-Schmidt R, Schnohr P, Jensen GB, Nordestgaard BG, Tybjærg-Hansen A. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. Brit Med J 2011;343:d5497. doi:10.1136/bmj.d5497
Go to original source...
Go to PubMed...
- Zeman M, ®ák A, Herdová J. An analysis of plasma lipids and clinical characteristics of patients with xanthelasma palpebrarum (in Czech). Čas Lék čes 1981;120(26):806-8.
- ©obra J. Inherited disorders of the lipid metabolism (in Czech). In: Hyánek J, editor. Clinical and biochemical aspects of inherited metabolic disorders. Praha: Avicenum; 1980, p. 200-240.
- Junyent M, Gilabert R, Zambón D, Núñez I, Vela M, Civeira F, Pocoví M, Ros E. The use of Achilles tendon sonography to distinguish familial hypercholesterolemia from other genetic dyslipidemias. Arterioscler Thromb Vasc Biol 2005;25(10):2203-8.
Go to original source...
Go to PubMed...
- Leaf DA. Chylomicronemia and the chylomicronemia syndrome: a practical approach to management. Am J Med 2008;121(1):10-2.
Go to original source...
Go to PubMed...
- Sandhu S, Al-Sarraf A, Taraboanta C, Frohlich J, Francis GA. Incidence of pancreatitis, secondary causes, and treatment of patients referred to specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study. Lipids Health Dis 2011;10:157. doi: 10.1186/1476-511X-10-157
Go to original source...
Go to PubMed...
- Menotti A, Puddu PE, Lanti M, Maiani G, Fidanza F. Cardiovascular risk factors predict survival in middle-aged men during 50 years. Eur J Intern Med 2013;24(1):67-74.
Go to original source...
Go to PubMed...
- Targher G, Byrne CD. Nonalcoholic fatty liver disease: A novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab 2013;98(2):483-95.
Go to original source...
Go to PubMed...
- Pandhi D, Gupta P, Singal A, Tondon A, Sharma S, Madhu SV. Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma). Postgrad Med J 2012;88(1038):198-204.
Go to original source...
Go to PubMed...
- Oosterveer DM, Versmissen J, Yazdanpanah M, Hamza TH, Sijbrands EJ. Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and metaanalysis. Atherosclerosis 2009;207(2):311-7.
Go to original source...
Go to PubMed...
- Richter WO. Chylomicronemia and chylomicronemia syndrome. In: Gotto AM, Mancini M, Richter WO, Schwandt P, editors. Treatment of Severe Dyslipoproteinemia in the Prevention of Coronary Heart Disease 3, Basel: Karger; 1992, p. 165-173.
- Tsouli SG, Xydis V, Argyropoulou MI, Tselepis AD, Elisaf M, Kiortsis DN. Regression of Achilles tendon thickness after statin treatment in patients with familial hypercholesterolemia: an ultrasonographic study. Atherosclerosis 2009;205(1):151-5.
Go to original source...
Go to PubMed...
- Civeira F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 2004;173(1):55-68.
Go to original source...
Go to PubMed...
- Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Borén J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AFH, Stroes E, Taskinen M-G, Tybjærg-Hansen A. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. European Heart Journal 2013;34(5):3478-90.
Go to original source...
Go to PubMed...
- Cheng WF, Yuen YP, Chow CB, Au KM, Chan YW, Tam SC. Sitosterolaemia and xanthomatosis in a child. Hong Kong Med J 2003;9(3):206-9.
Go to PubMed...
- Expert Panel on Dyslipidemia, Grundy SM, Arai H, Bartere P, Bersot TP, Betteridge DJ, Carmena R, Cuevas A, Davidson MH, Genest J, Kesäniemi YA, Sadikot S, Santos RD, Susekov A, Sy R, Tokgozoglu L, Watts GF, Zhao D. An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia: Executive summary. Atherosclerosis 2014; 232(2):410-3.
Go to original source...
Go to PubMed...
- Park JR, Jung TS, Jung JH, Lee GW, Kim MA, Park KJ, Kim DR, Chang SH, Chung SI, Hahm JR. A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas. J Korean Med Sci 2005;20(3):502-5.
Go to original source...
Go to PubMed...
- Moroney PJ, Besse JL. Resection of bilateral massive Achilles tendon xanthomata with reconstruction using a flexor hallucis longus tendon transfer and Bosworth turndown flap: a case report and literature review. Foot Ankle Surg 2012;18(3):e25-e28.
Go to original source...
Go to PubMed...
- Cannon PS, Ajit R, Leatherbarrow B. Efficacy of trichloracetic acid (95%) in the management of xanthelasma palpebrarum. Clin Exp Dermatol 2010;35(8):845-8.
Go to original source...
Go to PubMed...
- Ghosh YK, Pradhan E, Ahluwalia HS. Excision of xanthelasmata - clamp, shave, and suture. Int J Dermatol 2009;48(2):181-3.
Go to original source...
Go to PubMed...